Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgia Zucchini

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|May 9, 2017
Hormone-receptor positive breast cancer: highlights from the 39<sup>TH</sup> San Antonio Breast Cancer SymposiumGiorgia Zucchini, Filippo Montemurro
International Journal of Women'S Health|June 12, 2015
Clinical utility of exemestane in the treatment of breast cancerGiorgia Zucchini, Elena Geuna, Andrea Milani, et al.
Molecular and Cellular Endocrinology|August 13, 2013
Breast cancer: current and future endocrine therapiesCarlo Palmieri, Darren K Patten, Adam Januszewski, et al.
Minerva Ginecologica|January 23, 2016
Breast cancer in BRCA mutation carriers: medical treatmentAndrea Milani, Elena Geuna, Giorgia Zucchini, et al.
JOP : Journal of the Pancreas|September 7, 2010
A bizarre abdominal cystic lesionGiorgia Zucchini, Raffaele Pezzilli, Claudio Ricci, et al.
Expert Opinion on Investigational Drugs|February 12, 2016
Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancerRossella Martinello, Andrea Milani, Elena Geuna, et al.
Breast Cancer Research and Treatment|April 1, 2010
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excisionIsacco Montroni, Donatella Santini, Giorgia Zucchini, et al.
Expert Opinion on Pharmacotherapy|September 21, 2016
New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancerRossella Martinello, Sofia Genta, Danilo Galizia, et al.
Expert Review of Anticancer Therapy|May 5, 2015
Linifanib: current status and future potential in cancer therapyCaterina Aversa, Francesco Leone, Giorgia Zucchini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2013
18F-FDG PET/CT impact on testicular tumours clinical managementValentina Ambrosini, Giorgia Zucchini, Silvia Nicolini, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|May 9, 2017
Hormone-receptor positive breast cancer: highlights from the 39<sup>TH</sup> San Antonio Breast Cancer SymposiumGiorgia Zucchini, Filippo Montemurro
International Journal of Women'S Health|June 12, 2015
Clinical utility of exemestane in the treatment of breast cancerGiorgia Zucchini, Elena Geuna, Andrea Milani, et al.
Molecular and Cellular Endocrinology|August 13, 2013
Breast cancer: current and future endocrine therapiesCarlo Palmieri, Darren K Patten, Adam Januszewski, et al.
Minerva Ginecologica|January 23, 2016
Breast cancer in BRCA mutation carriers: medical treatmentAndrea Milani, Elena Geuna, Giorgia Zucchini, et al.
JOP : Journal of the Pancreas|September 7, 2010
A bizarre abdominal cystic lesionGiorgia Zucchini, Raffaele Pezzilli, Claudio Ricci, et al.
Expert Opinion on Investigational Drugs|February 12, 2016
Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancerRossella Martinello, Andrea Milani, Elena Geuna, et al.
Breast Cancer Research and Treatment|April 1, 2010
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excisionIsacco Montroni, Donatella Santini, Giorgia Zucchini, et al.
Expert Opinion on Pharmacotherapy|September 21, 2016
New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancerRossella Martinello, Sofia Genta, Danilo Galizia, et al.
Expert Review of Anticancer Therapy|May 5, 2015
Linifanib: current status and future potential in cancer therapyCaterina Aversa, Francesco Leone, Giorgia Zucchini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2013
18F-FDG PET/CT impact on testicular tumours clinical managementValentina Ambrosini, Giorgia Zucchini, Silvia Nicolini, et al.
Pageof 2